Both Democratic presidential front runner Hillary Clinton and GOP hopeful Donald Trump support the right for the government to negotiate Medicare drug costs. Additionally, Clinton has previously stated she would tackle “price gouging” from drugmakers if she is elected.
[related_stories]Smead Capital Management CEO Bill Smead told CNBC, though, argues that investors are missing a buying opportunity in the health care sector as the area lags behind the broader equities market.
“A breakout here would likely target a re-test of the highs (mid-70’s). But should XLV struggle here… then all eyes on that bull market trend line,” adds See It Market.
Health Care Select Sector SPDR
